U.S. markets open in 1 hour 56 minutes

SenesTech, Inc. (SNES)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.4060+0.0370 (+10.03%)
At close: 03:59PM EDT
0.4200 +0.01 (+3.45%)
After hours: 05:06PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close0.3690
Bid0.0000 x 4000
Ask0.0000 x 900
Day's Range0.3800 - 0.4000
52 Week Range0.3370 - 1.6850
Avg. Volume37,958
Market Cap4.958M
Beta (5Y Monthly)1.17
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for SNES

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • SenesTech, Inc.
    Analyst Report: ICON Public Limited CompanyIcon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
    Fair Value
    Economic Moat
    7 days agoMorningstar
View more
  • Zacks

    Senestech, Inc. (SNES) Reports Q2 Loss, Lags Revenue Estimates

    Senestech, Inc. (SNES) delivered earnings and revenue surprises of -10.53% and 24.52%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Insider Monkey

    Is SenesTech (SNES) A Great Long-Term Investment?

    Long Cast Advisers, an investment management firm, published its fourth-quarter 2021 investor letter – a copy of which can be downloaded here. For the 4Q21 quarter (ended December 31, 2021), cumulative net returns of the fund were flat. For the year, net returns were 42%. Since inception in November 2015 through quarter-end 3Q21, LCA returned […]

  • American City Business Journals

    Meet SenesTech, the Phoenix company making birth control for rats

    Controlling rat populations has been a problem for centuries, but inducing infertility offers an alternative way to slow down quick-breeding rats. After years of laying the groundwork, SenesTech recently launched a new marketing campaign as it heads for full commercialization. “I think this [company] is a rocket ship. And the question is, how do we actually achieve liftoff?" SenesTech's CEO said.